Global Neurological Biomarkers Competitive Landscape Professional Research Report 2024

Research Summary

Neurological biomarkers are measurable indicators or characteristics that provide information about the state or function of the nervous system. These biomarkers can include various physiological, biochemical, or imaging-based measurements that are associated with normal neurological function or specific neurological conditions or diseases. Examples of neurological biomarkers include specific proteins or molecules found in cerebrospinal fluid or blood, abnormalities or patterns observed in brain imaging scans (such as magnetic resonance imaging or positron emission tomography), and electrical activity recorded from the brain (such as electroencephalography). Neurological biomarkers can help in the diagnosis, prognosis, and monitoring of neurological disorders, as well as in the development and evaluation of new treatments and interventions. They serve as objective measures that complement clinical assessments, aiding in the understanding of disease progression, response to therapy, and the identification of potential therapeutic targets.

According to DIResearch's in-depth investigation and research, the global Neurological Biomarkers market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Neurological Biomarkers include Thermo Fisher Scientific, Merck, Quest Diagnostics, Roche, Abbott, QIAGEN, Bio-Rad Laboratories, Illumina, Cisbio Bioassays, Myriad RBM, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Neurological Biomarkers. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neurological Biomarkers market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neurological Biomarkers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neurological Biomarkers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Neurological Biomarkers Include:

Thermo Fisher Scientific

Merck

Quest Diagnostics

Roche

Abbott

QIAGEN

Bio-Rad Laboratories

Illumina

Cisbio Bioassays

Myriad RBM

Athena Diagnostics

BGI

Wuxi APP

Aepodia

Proteome Sciences

Genewiz

Neurological Biomarkers Product Segment Include:

Proteomics

Genomics

Imaging

Bioinformatics

Others

Neurological Biomarkers Product Application Include:

Diagnostics

Drug Discovery

Personalized Medicine

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Neurological Biomarkers Industry PESTEL Analysis

Chapter 3: Global Neurological Biomarkers Industry Porter's Five Forces Analysis

Chapter 4: Global Neurological Biomarkers Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Neurological Biomarkers Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Neurological Biomarkers Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Neurological Biomarkers Market Overview

1.1 Product Definition and Statistical Scope

1.2 Neurological Biomarkers Product by Type

1.2.1 Global Neurological Biomarkers Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Proteomics

1.2.3 Genomics

1.2.4 Imaging

1.2.5 Bioinformatics

1.2.6 Others

1.3 Neurological Biomarkers Product by Application

1.3.1 Global Neurological Biomarkers Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Global Neurological Biomarkers Market Revenue and Sales Analysis

1.4.1 Global Neurological Biomarkers Market Size Analysis (2019-2030)

1.4.2 Global Neurological Biomarkers Market Sales Analysis (2019-2030)

1.4.3 Global Neurological Biomarkers Market Sales Price Trend Analysis (2019-2030)

1.5 Neurological Biomarkers Market Development Status and Trends

1.5.1 Neurological Biomarkers Industry Development Status Analysis

1.5.2 Neurological Biomarkers Industry Development Trends Analysis

2 Neurological Biomarkers Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Neurological Biomarkers Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Neurological Biomarkers Market Analysis by Regions

4.1 Neurological Biomarkers Overall Market: 2023 VS 2024 VS 2030

4.2 Global Neurological Biomarkers Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Neurological Biomarkers Revenue and Market Share by Region (2019-2024)

4.2.2 Global Neurological Biomarkers Revenue Forecast by Region (2025-2030)

4.3 Global Neurological Biomarkers Sales and Forecast Analysis (2019-2030)

4.3.1 Global Neurological Biomarkers Sales and Market Share by Region (2019-2024)

4.3.2 Global Neurological Biomarkers Sales Forecast by Region (2025-2030)

4.4 Global Neurological Biomarkers Sales Price Trend Analysis (2019-2030)

5 Global Neurological Biomarkers Market Size by Type and Application

5.1 Global Neurological Biomarkers Market Size by Type

5.1.1 Global Neurological Biomarkers Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Neurological Biomarkers Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Neurological Biomarkers Market Size by Application

5.2.1 Global Neurological Biomarkers Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Neurological Biomarkers Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Neurological Biomarkers Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Neurological Biomarkers Market Size by Type

6.3.1 North America Neurological Biomarkers Sales by Type (2019-2030)

6.3.2 North America Neurological Biomarkers Revenue by Type (2019-2030)

6.4 North America Neurological Biomarkers Market Size by Application

6.4.1 North America Neurological Biomarkers Sales by Application (2019-2030)

6.4.2 North America Neurological Biomarkers Revenue by Application (2019-2030)

6.5 North America Neurological Biomarkers Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Neurological Biomarkers Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Neurological Biomarkers Market Size by Type

7.3.1 Europe Neurological Biomarkers Sales by Type (2019-2030)

7.3.2 Europe Neurological Biomarkers Revenue by Type (2019-2030)

7.4 Europe Neurological Biomarkers Market Size by Application

7.4.1 Europe Neurological Biomarkers Sales by Application (2019-2030)

7.4.2 ? Europe Neurological Biomarkers Revenue by Application (2019-2030)

7.5 Europe Neurological Biomarkers Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Neurological Biomarkers Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Neurological Biomarkers Market Size by Type

8.3.1 China Neurological Biomarkers Sales by Type (2019-2030)

8.3.2 China Neurological Biomarkers Revenue by Type (2019-2030)

8.4 China Neurological Biomarkers Market Size by Application

8.4.1 China Neurological Biomarkers Sales by Application (2019-2030)

8.4.2 China Neurological Biomarkers Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Neurological Biomarkers Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Neurological Biomarkers Market Size by Type

9.3.1 APAC (excl. China) Neurological Biomarkers Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Neurological Biomarkers Revenue by Type (2019-2030)

9.4 APAC (excl. China) Neurological Biomarkers Market Size by Application

9.4.1 APAC (excl. China) Neurological Biomarkers Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Neurological Biomarkers Revenue by Application (2019-2030)

9.5 APAC (excl. China) Neurological Biomarkers Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Neurological Biomarkers Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Neurological Biomarkers Market Size by Type

10.3.1 Latin America Neurological Biomarkers Sales by Type (2019-2030)

10.3.2 Latin America Neurological Biomarkers Revenue by Type (2019-2030)

10.4 Latin America Neurological Biomarkers Market Size by Application

10.4.1 Latin America Neurological Biomarkers Sales by Application (2019-2030)

10.4.2 Latin America Neurological Biomarkers Revenue by Application (2019-2030)

10.5 Latin America Neurological Biomarkers Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Neurological Biomarkers Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Neurological Biomarkers Market Size by Type

11.3.1 Middle East & Africa Neurological Biomarkers Sales by Type (2019-2030)

11.3.2 Middle East & Africa Neurological Biomarkers Revenue by Type (2019-2030)

11.4 Middle East & Africa Neurological Biomarkers Market Size by Application

11.4.1 Middle East & Africa Neurological Biomarkers Sales by Application (2019-2030)

11.4.2 Middle East & Africa Neurological Biomarkers Revenue by Application (2019-2030)

11.5 Middle East & Africa Neurological Biomarkers Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Neurological Biomarkers Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Neurological Biomarkers Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Neurological Biomarkers Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Neurological Biomarkers Average Sales Price by Manufacturers (2020-2024)

12.2 Neurological Biomarkers Competitive Landscape Analysis and Market Dynamic

12.2.1 Neurological Biomarkers Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Thermo Fisher Scientific

13.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Portfolio

13.1.3 Thermo Fisher Scientific Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Merck

13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Merck Neurological Biomarkers Product Portfolio

13.2.3 Merck Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Quest Diagnostics

13.3.1 Quest Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Quest Diagnostics Neurological Biomarkers Product Portfolio

13.3.3 Quest Diagnostics Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Roche

13.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Roche Neurological Biomarkers Product Portfolio

13.4.3 Roche Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Abbott

13.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Abbott Neurological Biomarkers Product Portfolio

13.5.3 Abbott Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 QIAGEN

13.6.1 QIAGEN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 QIAGEN Neurological Biomarkers Product Portfolio

13.6.3 QIAGEN Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Bio-Rad Laboratories

13.7.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Portfolio

13.7.3 Bio-Rad Laboratories Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Illumina

13.8.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Illumina Neurological Biomarkers Product Portfolio

13.8.3 Illumina Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Cisbio Bioassays

13.9.1 Cisbio Bioassays Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Cisbio Bioassays Neurological Biomarkers Product Portfolio

13.9.3 Cisbio Bioassays Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Myriad RBM

13.10.1 Myriad RBM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Myriad RBM Neurological Biomarkers Product Portfolio

13.10.3 Myriad RBM Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 Athena Diagnostics

13.11.1 Athena Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Athena Diagnostics Neurological Biomarkers Product Portfolio

13.11.3 Athena Diagnostics Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.12 BGI

13.12.1 BGI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 BGI Neurological Biomarkers Product Portfolio

13.12.3 BGI Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.13 Wuxi APP

13.13.1 Wuxi APP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Wuxi APP Neurological Biomarkers Product Portfolio

13.13.3 Wuxi APP Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.14 Aepodia

13.14.1 Aepodia Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Aepodia Neurological Biomarkers Product Portfolio

13.14.3 Aepodia Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.15 Proteome Sciences

13.15.1 Proteome Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Proteome Sciences Neurological Biomarkers Product Portfolio

13.15.3 Proteome Sciences Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.16 Genewiz

13.16.1 Genewiz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Genewiz Neurological Biomarkers Product Portfolio

13.16.3 Genewiz Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Neurological Biomarkers Industry Chain Analysis

14.2 Neurological Biomarkers Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Neurological Biomarkers Typical Downstream Customers

14.4 Neurological Biomarkers Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support